September 11, 2017
Dr. Antoni Ribas in the lab. Photo courtesy of: UCLA Jonsson Comprehensive Cancer Center
Stories this photo appears in:
Scientists at UCLA have launched the first genetically engineered blood stem cell clinical trial to fight cancer thanks to $20 million in voter-approved funds earmarked for stem cell research, university officials announced Monday.